CYTOMX THERAPEUTICS INC. - COMMON STOCK

CytomX Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

05 يناير 2022 05:00:03 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces Preliminary Results for Ongoing Phase 2 Expansion Study of CX-2029, a First-in-Class Antibody-Drug Conjugate Candidate Targeting the Transferrin Receptor, CD71

20 ديسمبر 2021 13:05:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming November Investor Conferences

11 نوفمبر 2021 05:00:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update

04 نوفمبر 2021 13:15:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Cytokine Platform at Society for Immunotherapy of Cancer Annual Meeting

01 نوفمبر 2021 05:00:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Announce Third Quarter 2021 Financial Results on November 4, 2021

28 أكتوبر 2021 05:00:03 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

18 أكتوبر 2021 05:00:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Appoints Dr. Alan Ashworth to Board of Directors

04 أكتوبر 2021 05:00:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

16 سبتمبر 2021 05:00:02 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference

07 سبتمبر 2021 05:00:02 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

17 أغسطس 2021 05:00:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update

05 أغسطس 2021 13:15:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces Multiple Publications on Pacmilimab (CX-072), a Conditionally Activated Inhibitor of Programmed Death-Ligand 1 (PD-L1)

04 أغسطس 2021 05:00:02 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming August Investor Conferences

02 أغسطس 2021 05:00:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021

29 يوليو 2021 05:00:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces Publication of First-in-Human Data for CX-2029 in Clinical Cancer Research

21 يونيو 2021 05:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Jefferies Virtual Healthcare Conference

27 مايو 2021 05:00:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update

06 مايو 2021 13:15:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Announce First Quarter 2021 Financial Results on May 6, 2021

29 أبريل 2021 05:00:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

14 أبريل 2021 13:01:00 بحسب Nasdaq GlobeNewswire